サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1786446

疾病管理アプリの世界市場

Disease Management Apps

出版日
ページ情報
英文 232 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.66円
疾病管理アプリの世界市場
出版日: 2025年08月08日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 232 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

疾病管理アプリの世界市場は2030年までに253億米ドルに達する見込み

2024年に120億米ドルと推定される疾病管理アプリの世界市場は、2024年から2030年にかけて13.2%のCAGRで成長し、2030年には253億米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるiOSプラットフォームは、CAGR12.4%を記録し、分析期間終了時には145億米ドルに達すると予測されます。Androidプラットフォームセグメントの成長率は、分析期間のCAGRで14.9％と推定されます。

米国市場は32億米ドル、中国はCAGR 12.4％で成長すると予測

米国の疾病管理アプリ市場は、2024年に32億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに39億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは12.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ12.0％と11.4％と予測されています。欧州では、ドイツがCAGR約9.7%で成長すると予測されています。

世界の疾病管理アプリ市場- 主要動向と促進要因まとめ

デジタルヘルス技術が疾病管理を再形成？

デジタルヘルス技術の急速な導入は、リアルタイムでの患者モニタリング、個別化された治療計画、ヘルスケアへのアクセス性向上を可能にし、疾病管理に変革をもたらしつつあります。疾病管理アプリはこの革命の最前線にあり、患者が症状、服薬アドヒアランス、ライフスタイルの改善を追跡するのに役立つモバイルおよびクラウドベースのプラットフォームを提供しています。これらのアプリは、ウェアラブルデバイス、電子カルテ（EHR）、AI主導のアナリティクスと統合され、ヘルスケア専門家にプロアクティブケアのための貴重な洞察を提供します。糖尿病、高血圧、心血管障害などの慢性疾患は、患者が自分の状態を自己管理するための便利なツールを求めているため、アプリ導入の主な促進要因となっています。しかし、データ・プライバシー、規制遵守、デジタル・リテラシーに対する懸念が依然として課題となっています。このようなハードルにもかかわらず、疾病管理アプリは患者とヘルスケアプロバイダーの双方にとって不可欠なツールとなりつつあり、テクノロジー主導のソリューションを通じて慢性疾患ケアに革命をもたらしています。

AIと機械学習はどのように疾患モニタリングを強化しているのか？

人工知能（AI）と機械学習（ML）は、疾病管理アプリの改善において重要な役割を果たしており、予測分析、自動ヘルスコーチング、パーソナライズされた推奨を可能にしています。AIを搭載したアルゴリズムは、患者データを分析して早期警告の兆候を特定し、タイムリーな介入を可能にし、病気の合併症を予防します。チャットボットとバーチャル・アシスタントは、即時サポート、服薬リマインダー、ライフスタイルの推奨を提供することで、患者エンゲージメントを強化しています。さらに、AI主導の症状チェッカーは、ユーザーが医師に相談する前に健康状態を評価するのに役立っています。このような進歩にもかかわらず、アルゴリズムの偏り、データ・セキュリティ・リスク、規制当局の承認プロセスなどの課題が、AIの普及を阻んでいます。しかし、AI技術が成熟するにつれて、疾病管理アプリにおけるその役割は拡大し、ヘルスケアをより予測的で、データ駆動型で、利用しやすいものにすることが期待されています。

疾病管理アプリは遠隔患者モニタリングと遠隔医療を改善できるか？

遠隔医療や遠隔患者モニタリングの台頭が疾病管理アプリの需要に拍車をかけています。ヘルスケアプロバイダーは、臨床現場以外で患者を管理する効率的な方法を模索しているからです。これらのアプリにより、医師は患者の経過を追跡し、リアルタイムの健康状態のアップデートを受け取り、継続的なモニタリングデータに基づいて治療計画を調整することができます。喘息、関節炎、精神疾患などの慢性疾患の遠隔管理は、病院への受診を減らし、ヘルスケアシステムの負担を軽減し、患者の転帰を改善しています。さらに、モバイルヘルス（mヘルス）アプリケーションは、術後の回復、リハビリテーション、緩和ケアの管理において重要な役割を果たしています。しかし、インターネットアクセスやデジタルヘルスリテラシーの格差は、公平な導入のために対処しなければならない課題です。ヘルスケアがバリューベースのケアモデルへとシフトする中、疾病管理アプリは、遠隔地での継続的かつ患者中心のヘルスケア提供を可能にする不可欠なツールとなることが期待されています。

疾病管理アプリ市場の成長の原動力は？

疾病管理アプリ市場の成長は、慢性疾患の増加、AIを活用したヘルスケア分析の進歩、遠隔医療サービスの拡大など、いくつかの要因によってもたらされます。遠隔患者モニタリングやデジタルヘルスソリューションに対する需要の高まりは、特に強固なヘルスケアインフラを持つ新興国市場でのアプリ採用をさらに加速させています。さらに、ヘルステック新興企業やデジタル治療薬（DTx）への投資の増加が、疾病管理アプリケーションの技術革新を促進しています。デジタルヘルスケアを推進する政府の取り組みも、モバイルヘルスソリューションに対する有利な償還政策と相まって、市場の成長を後押ししています。データプライバシーに関する懸念、規制遵守、技術格差などの課題は依然として残っているが、AI、クラウドコンピューティング、モバイルヘルスにおける継続的な進歩が疾病管理アプリ市場を前進させ、デジタル疾病管理を現代ヘルスケアの標準的な構成要素にすると予想されます。

セグメント

プラットフォーム（iOSプラットフォーム、Androidプラットフォーム、その他のプラットフォーム）、デバイス（スマートフォン、タブレット、ウェアラブルデバイス）、適応症（肥満、心血管疾患、メンタルヘルス、糖尿病、その他の適応症）

調査対象企業の例

  • Acronis International GmbH
  • Arcserve LLC
  • Axcient Inc.
  • Carbonite, Inc.
  • Cohesity Inc.
  • Datto, a Kaseya Company
  • Dell Technologies Inc.
  • IBM Corporation
  • Microsoft Corporation
  • N-able Technologies Ltd.
  • Oracle Corporation
  • Quorum Labs, Inc.
  • Rubrik, Inc.
  • StorageCraft Technology Corporation
  • Unitrends, a Kaseya Company
  • Veeam Software Group
  • Veritas Technologies LLC
  • VMware, Inc.
  • Zerto, a Hewlett Packard Enterprise Company

AIインテグレーション

私たちは、検証された専門家のコンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP30535

Global Disease Management Apps Market to Reach US$25.3 Billion by 2030

The global market for Disease Management Apps estimated at US$12.0 Billion in the year 2024, is expected to reach US$25.3 Billion by 2030, growing at a CAGR of 13.2% over the analysis period 2024-2030. iOS Platform, one of the segments analyzed in the report, is expected to record a 12.4% CAGR and reach US$14.5 Billion by the end of the analysis period. Growth in the Android Platform segment is estimated at 14.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.2 Billion While China is Forecast to Grow at 12.4% CAGR

The Disease Management Apps market in the U.S. is estimated at US$3.2 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 12.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 12.0% and 11.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.

Global Disease Management Apps Market - Key Trends & Drivers Summarized

Are Digital Health Technologies Reshaping Disease Management?

The rapid adoption of digital health technologies is transforming disease management, enabling real-time patient monitoring, personalized treatment plans, and enhanced healthcare accessibility. Disease management apps are at the forefront of this revolution, offering mobile and cloud-based platforms that help patients track symptoms, medication adherence, and lifestyle modifications. These apps integrate with wearable devices, electronic health records (EHRs), and AI-driven analytics, providing healthcare professionals with valuable insights for proactive care. Chronic diseases such as diabetes, hypertension, and cardiovascular disorders are major drivers of app adoption, as patients seek convenient tools to self-manage their conditions. However, concerns over data privacy, regulatory compliance, and digital literacy continue to pose challenges. Despite these hurdles, disease management apps are becoming indispensable tools for both patients and healthcare providers, revolutionizing chronic disease care through technology-driven solutions.

How Is AI and Machine Learning Enhancing Disease Monitoring?

Artificial intelligence (AI) and machine learning (ML) are playing a crucial role in improving disease management apps, enabling predictive analytics, automated health coaching, and personalized recommendations. AI-powered algorithms analyze patient data to identify early warning signs, allowing for timely intervention and preventing disease complications. Chatbots and virtual health assistants are enhancing patient engagement by providing instant support, medication reminders, and lifestyle recommendations. Additionally, AI-driven symptom checkers are helping users assess their health conditions before consulting a physician. Despite these advancements, challenges such as algorithm biases, data security risks, and regulatory approval processes remain barriers to widespread AI integration. However, as AI technology matures, its role in disease management apps is expected to expand, making healthcare more predictive, data-driven, and accessible.

Can Disease Management Apps Improve Remote Patient Monitoring and Telemedicine?

The rise of telemedicine and remote patient monitoring is fueling the demand for disease management apps, as healthcare providers seek efficient ways to manage patients outside clinical settings. These apps enable doctors to track patient progress, receive real-time health updates, and adjust treatment plans based on continuous monitoring data. Remote management of chronic conditions such as asthma, arthritis, and mental health disorders is reducing hospital visits, easing the burden on healthcare systems, and improving patient outcomes. Additionally, mobile health (mHealth) applications are playing a key role in managing post-operative recovery, rehabilitation, and palliative care. However, disparities in internet access and digital health literacy are challenges that must be addressed for equitable adoption. As healthcare shifts toward value-based care models, disease management apps are expected to become essential tools in enabling remote, continuous, and patient-centric healthcare delivery.

What Is Driving the Growth of the Disease Management Apps Market?

The growth in the disease management apps market is driven by several factors, including the increasing prevalence of chronic diseases, advancements in AI-powered healthcare analytics, and the expansion of telemedicine services. The rising demand for remote patient monitoring and digital health solutions is further accelerating app adoption, particularly in developed markets with robust healthcare infrastructure. Additionally, growing investments in health tech startups and digital therapeutics (DTx) are driving innovation in disease management applications. Government initiatives promoting digital healthcare, coupled with favorable reimbursement policies for mobile health solutions, are also boosting market growth. While challenges such as data privacy concerns, regulatory compliance, and technological disparities persist, continued advancements in AI, cloud computing, and mobile health are expected to propel the disease management apps market forward, making digital disease management a standard component of modern healthcare.

SCOPE OF STUDY:

The report analyzes the Disease Management Apps market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Platform (iOS Platform, Android Platform, Other Platforms); Device (Smartphones, Tablets, Wearable Devices); Indication (Obesity, Cardiovascular Issues, Mental Health, Diabetes, Other Indications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 43 Featured) -

  • Acronis International GmbH
  • Arcserve LLC
  • Axcient Inc.
  • Carbonite, Inc.
  • Cohesity Inc.
  • Datto, a Kaseya Company
  • Dell Technologies Inc.
  • IBM Corporation
  • Microsoft Corporation
  • N-able Technologies Ltd.
  • Oracle Corporation
  • Quorum Labs, Inc.
  • Rubrik, Inc.
  • StorageCraft Technology Corporation
  • Unitrends, a Kaseya Company
  • Veeam Software Group
  • Veritas Technologies LLC
  • VMware, Inc.
  • Zerto, a Hewlett Packard Enterprise Company

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Disease Management Apps - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Chronic Diseases Drives Increased Adoption of Disease Management Apps for Remote Monitoring
    • Surge in Healthcare Digitization and Telemedicine Expands the Addressable Market for Disease Management Applications
    • Growing Consumer Preference for Self-Management Tools Accelerates Demand for Mobile Disease Management Apps
    • Technological Advancements in Wearables and IoT Devices Strengthen the Integration of Disease Management Apps with Real-Time Data
    • Regulatory Push for Better Healthcare Accessibility and Patient-Centric Care Propels Growth in Disease Management App Market
    • Increasing Focus on Preventive Healthcare and Early Intervention Strengthens the Adoption of Disease Management Solutions
    • Surge in Healthcare Insurance Providers Offering Digital Tools Expands the Reach and Adoption of Disease Management Apps
    • Rising Interest in Personalized Medicine and Tailored Treatment Plans Drives the Demand for Customized Disease Management Applications
    • Growth in Digital Health Funding and Investment Expands the Innovation Potential and Market Reach of Disease Management Apps
    • The Need for Efficient Chronic Disease Monitoring and Compliance Drives Demand for Disease Management Apps in Home Healthcare
    • Integration of AI and Machine Learning in Disease Management Apps Improves Diagnostic Accuracy and Treatment Recommendations
    • The Shift Toward Value-Based Healthcare Models Accelerates the Adoption of Disease Management Apps for Better Patient Outcomes
    • Increasing Incidence of Mental Health Disorders and Stress-Related Conditions Drives Growth in Disease Management Apps for Mental Health
    • Surge in Use of Mobile Health (mHealth) Apps to Manage Non-Communicable Diseases Expands Market Opportunities for Disease Management Apps
    • Growing Focus on Mobile-Based Disease Tracking Tools for Maternal and Child Health Strengthens Demand in Global Health Markets
    • Expansion of Chronic Care Management Programs in Developed and Developing Economies Drives Global Adoption of Disease Management Apps
    • The Rise in Social Media and Health Communities Drives Consumer Education and Adoption of Disease Management Apps
    • Increasing Integration of Disease Management Apps with Electronic Health Records (EHR) Systems Improves Coordination of Care
    • Growing Awareness of Health Data Privacy and Security Strengthens Trust and Adoption of Secure Disease Management Platforms
    • Surge in Healthcare Reform and Policies Supporting Digital Health Tools Drives Market Growth for Disease Management Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Disease Management Apps Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Disease Management Apps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Disease Management Apps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Disease Management Apps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for iOS Platform by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for iOS Platform by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for iOS Platform by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Android Platform by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Android Platform by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Android Platform by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Platforms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Platforms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Obesity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Obesity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Cardiovascular Issues by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Cardiovascular Issues by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Cardiovascular Issues by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Mental Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Mental Health by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Mental Health by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Smartphones by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Smartphones by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Smartphones by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Tablets by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Tablets by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Wearable Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Wearable Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Wearable Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Disease Management Apps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
  • JAPAN
    • Disease Management Apps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
  • CHINA
    • Disease Management Apps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
  • EUROPE
    • Disease Management Apps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Disease Management Apps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Disease Management Apps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Disease Management Apps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
  • FRANCE
    • Disease Management Apps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
  • GERMANY
    • Disease Management Apps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Disease Management Apps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Disease Management Apps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Disease Management Apps by Platform - iOS Platform, Android Platform and Other Platforms Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Disease Management Apps by Platform - Percentage Breakdown of Value Sales for iOS Platform, Android Platform and Other Platforms for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Disease Management Apps by Indication - Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Disease Management Apps by Indication - Percentage Breakdown of Value Sales for Diabetes, Other Indications, Obesity, Cardiovascular Issues and Mental Health for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Disease Management Apps by Device - Smartphones, Tablets and Wearable Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Disease Management Apps by Device - Percentage Breakdown of Value Sales for Smartphones, Tablets and Wearable Devices for the Years 2015, 2025 & 2030

IV. COMPETITION